02348: Whole Blood Transcriptome Profiling of Dogs with Immune-Mediated Hemolytic Anemia (IMHA)
Grant Status: Closed
Immune-mediated hemolytic anemia, or IMHA, is a common autoimmune disease in dogs in which the body's immune system attacks its own red blood cells. Red blood cells are critical for transporting oxygen. Many dogs affected by IMHA require extensive hospitalization and blood transfusions, and often have fatal disease-related complications. While dogs of every breed can get IMHA, many spaniel breeds are overrepresented. Despite its high morbidity and mortality, IMHA and its triggers are still not well understood, which hinders the potential to develop treatments and stop this disease in its early stages. In this study, the investigators will use RNA sequencing to evaluate the genes that are active in the blood of dogs who have been newly diagnosed with IMHA. Comparing this data with that of healthy dogs without IMHA will allow the investigators to determine which genes are turned on in the early stages of IMHA. Additionally, this data may have future use in determining if any specific genetic changes are associated with activating these early onset genes. The investigators hope to identify genes which might be novel therapeutic targets for intervention in IMHA and identifying specific variants in these genes may improve understanding of which dogs are at risk for developing IMHA.
Borchert, C., Herman, A., Roth, M., Brooks, A. C., & Friedenberg, S. G. (2020). RNA sequencing of whole blood in dogs with primary immune-mediated hemolytic anemia (IMHA) reveals novel insights into disease pathogenesis. PLOS ONE, 15(10), e0240975. https://doi.org/10.1371/journal.pone.0240975
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.